Combined Effect of Topical Nepafenac and Topical Anesthesia On Patients' Pain Perception During Intravitreal Anti-Vascular Endothelial Growth Factor Injection
Pakistan Journal of Ophthalmology · 01.07.2026 · 42 (3)
DOI: 10.36351/pjo.v42i3.2369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Ophthalmology, online erschienen am 01.07.2026. Verfasst von Philumena und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the effectiveness of topical Nepafenac (0.1%) eye drops as an adjunct to topical proparacaine for pain relief during intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, and to compare its effect with topical proparacaine alone. Study Design: Quasi-experimental study. Place and Duration of Study: Al-Shifa Trust Eye Hospital, Rawalpindifrom July 2025 to October 2025.
Methods
The study included 150 patients, 30-70 years of age, who underwent intravitreal anti-VEGF injections. Group A (n=75) was given only topical proparacaine, and Group B (n=75) was given combined topical proparacaine and topical Nepafenac (0.1%).Numeric Pain Rating Scale (NPRS) was used for pain.
Results
The mean age was 60±11years. There were 88 males (58.7%)and right eye was more commonly involved (n = 83, 55.3%). Diabetic patients (n=87, 58%), with proliferative diabetic retinopathy (n=42, 28%) being the most frequent indication for anti-VEGF. No statistically significant difference was observed (Chi-square test,p = 0.07) regarding pain scores between the two groups. Pearson's correlation analysis revealed a very weak and non-significant association of Nepafenac (0.1%)use and pain scores (Pearson correlation coefficient = 0.182,p = 0.26).Pain scores showed no significant association with age (p=0.53), gender (p=0.06), previous injections (p=0.10), or underlying diagnoses (p=0.20). However, a statistically significant difference in pain perception was observed between diabetic and non-diabetic patients (p = 0.015).
Conclusion
Topical Nepafenac (0.1%)does not alterthe pain perceptionduring intravitreal anti-VEGF injections.
Zitieren
APA
Philumena, Altaf, S., Shaheen, F., Balqees, S., & Alizai, A. H. K. (2026). Combined Effect of Topical Nepafenac and Topical Anesthesia On Patients' Pain Perception During Intravitreal Anti-Vascular Endothelial Growth Factor Injection. Pakistan Journal of Ophthalmology, 42(3). https://doi.org/10.36351/pjo.v42i3.2369
Vancouver
Philumena, Altaf S, Shaheen F, Balqees S, Alizai AHK. Combined Effect of Topical Nepafenac and Topical Anesthesia On Patients' Pain Perception During Intravitreal Anti-Vascular Endothelial Growth Factor Injection. Pakistan Journal of Ophthalmology. 2026;42(3). doi:10.36351/pjo.v42i3.2369
BibTeX
@article{Philumena2026,
author = {Philumena and Altaf, Sumaira and Shaheen, Fiza and Balqees, Sidra and Alizai, Ahmad Hasan Khan},
title = {Combined Effect of Topical Nepafenac and Topical Anesthesia On Patients' Pain Perception During Intravitreal Anti-Vascular Endothelial Growth Factor Injection},
journal = {Pakistan Journal of Ophthalmology},
year = {2026},
volume = {42},
number = {3},
doi = {10.36351/pjo.v42i3.2369}
}
EUVIMED